483
Modavar PharmaceuticalsModavar Pharmaceuticals – FDA 483, Nov 15, 2024
Record Details
An FDA inspection of Modavar Pharmaceuticals, LLC in Frederick, MD, revealed a significant deviation from established protocols. The firm failed to implement blinding procedures for analysts during IVRT studies, as required by their own Blinding Protocol. This indicates a lapse in adherence to internal study conduct procedures.
- Person
View Company Profile
ID · 13b5b9d8-3b1b-4a65-b0aa-c2286d4278b8
Other documents for Modavar Pharmaceuticals
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.